Table 1.
Recommendations for blood pressure (BP) lowering in patients with acute ischaemic stroke.
| Patients who are not candidates for recombinant tissue plasminogen activator | ||
|---|---|---|
| Agency | Threshold BP (systolic/diastolic) for starting treatment | Target BP level |
| AHA | >220/120 mmHg | Reduce 15–20% |
| ESO | >220/120 mmHg | |
| NSF (Australia) | >220/120 mmHg | Reduce by <20% |
| Patients who are candidates for recombinant tissue plasminogen activator | ||
| Agency | Threshold BP (systolic/diastolic) for starting treatment | Target BP level |
| AHA | >185/110 mmHg | <180/105 mmHg |
| ESO | >185/110 mmHg | <185/110 mmHg |
| NSF (Australia) | >185/110 mmHg | <180/105 mmHg |
AHA, American Heart Association; ESO, European Stroke Organisation; NSF, National Stroke Foundation.